Resources

Below are some helpful and educational resources for you, your practice and your patients:

My Biocon Biologics Provider Portal Online Enrollment
https://www.mybioconbiologicsportal.com

Patient Enrollment FormCoverage

Fulphila Patient BrochureCoverage

Experienced and caring My Biocon Biologics patient access specialists are available
  • Patient support services and resources are available 24 hours a day, 7 days a week, via the My Biocon Biologics portal at www.mybioconbiologicsportal.com
References:
  1. Fulphila® (pegfilgrastim-jmdb) injection. Prescribing information. 2023. Biocon Biologics Inc. Cambridge, MA.
  2. U.S. Food and Drug Administration. Biosimilars. Available at:
    https://www.fda.gov/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/therapeuticbiologicapplications/biosimilars/default.htm
    Accessed on: 10 August 2023.
  3. Vogel C, et al. J Clin Oncol. 2005;23:1178-1184.
  4. Waller, C.F., Ranganna, G.M., Pennella, E.J. et al. Ann Hematol. (2019) 98: 1217.
Mylan

You are now leaving the Fulphila® website

You are now leaving this Biocon Biologics affiliate site. Biocon Biologics is not responsible for the content of the site you are about to visit.

Cancel

Continue